Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Completion Of A Non-exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Elrombopag (patent-free Indication), Atc B02bx05 F.d.z. 01.10.25-30.09.27 (plus Extension Option 1x12 Month) 2026-02-17
Germany The Dak-gesundheit Is Initiating A Non-exclusive Discount Agreement For The Active Ingredient Dimethylfumarat (exclusively 240 Mg In Standard Size N3), Atc L04ax07, Effective From 01.10.2025 To 30.09.2027, With An Option For A 12-month Extension. The Proc 2026-02-17
Germany Pharmaceutical Discounts According To § 130a Para. 8 Sgb V As Part Of Openhouse Processes 2026-02-17
Germany Open House Drug Discount Agreements For The Active Ingredient Eltrombopag, Atc B02bx05, 67304 Eisenberg, Rhineland-palatinate 2026-02-17
Germany Open House Drug Discount Agreements For The Active Ingredient Eltrombopag, Atc B02bx05, 67304 Eisenberg, Rhineland-palatinate 2026-02-17
Thailand Announcement Of Bidding For The Purchase Of Heat-resistant Gloves Autoclave Gloves 50 Cm. Size 7/8 (m) Autoclave Gloves 50 Cm. Size 10/11 (l) 2026-02-17
Germany Completion Non -existing Discount Agreements According To § 130a Para. 8 Sgb V (openhousemodell) 2026-02-17
Germany Medicines Contracts With Accession Option 2026-02-17
Germany The Health Insurance Companies Aim To Conclude Discount Contracts With All Suitable Pharmaceutical Entrepreneurs According To § 130a Abs. 8 Sgb V For The Active Ingredients, Active Ingredient Combinations, Or Dosage Forms, Strengths, Or Finished Medicinal 2026-02-17
Austria Digital Mammography With Tomosynthesis, Tomosynthesis Targeted Biopsy And Contrast Enhanced Mammography 2026-02-17
Whats app